These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9298756)

  • 41. 2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
    McGuigan C; Derudas M; Quintiliani M; Andrei G; Snoeck R; Henson G; Balzarini J
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6264-7. PubMed ID: 19833513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.
    Robins MJ; Nowak I; Rajwanshi VK; Miranda K; Cannon JF; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2007 Aug; 50(16):3897-905. PubMed ID: 17622128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues.
    De Clercq E
    Med Res Rev; 2003 May; 23(3):253-74. PubMed ID: 12647310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus.
    McGuigan C; Bidet O; Derudas M; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem; 2009 Apr; 17(8):3025-7. PubMed ID: 19328697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antiviral activity of 6-chloropurine arabinoside and its 2'-deoxy-2'-fluoro derivative.
    Maruyama T; Sato Y; Oto Y; Takahashi Y; Snoeck R; Andrei G; Witvrouw M; De Clercq E
    Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2331-4. PubMed ID: 8996865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction.
    Lacey SF; Suzutani T; Powell KL; Purifoy DJ; Honess RW
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():623-30. PubMed ID: 1848597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, Anti-Varicella-Zoster Virus and Anti-Cytomegalovirus Activity of 4,5-Disubstituted 1,2,3-(1H)-Triazoles.
    Yuan WY; Chen X; Liu NN; Wen YN; Yang B; Andrei G; Snoeck R; Xiang YH; Wu YW; Jiang Z; Schols D; Zhang ZY; Wu QP
    Med Chem; 2019; 15(7):801-812. PubMed ID: 30411688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro.
    Shigeta S; Mori S; Kira T; Takahashi K; Kodama E; Konno K; Nagata T; Kato H; Wakayama T; Koike N; Saneyoshi M
    Antivir Chem Chemother; 1999 Jul; 10(4):195-209. PubMed ID: 10480738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents.
    Wang ZX; Duan W; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(1-2):41-58. PubMed ID: 11303562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
    Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
    Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
    Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
    J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity.
    Angell A; McGuigan C; Garcia Sevillano L; Snoeck R; Andrei G; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2004 May; 14(10):2397-9. PubMed ID: 15109620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro drug combination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil with anti-human immunodeficiency virus or anticancer nucleosides.
    Machida H; Ashida N; Ikeda T; Sakata S; Baba M; Shigeta S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):214-6. PubMed ID: 1317147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
    Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety.
    Onishi T; Mukai C; Nakagawa R; Sekiyama T; Aoki M; Suzuki K; Nakazawa H; Ono N; Ohmura Y; Iwayama S; Okunishi M; Tsuji T
    J Med Chem; 2000 Jan; 43(2):278-82. PubMed ID: 10649983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
    Deroose CM; Chitneni SK; Gijsbers R; Vermaelen P; Ibrahimi A; Balzarini J; Baekelandt V; Verbruggen A; Nuyts J; Debyser Z; Bormans GM; Mortelmans L
    Nucl Med Biol; 2012 Nov; 39(8):1266-74. PubMed ID: 22981986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
    Machida H; Nishitani M; Ashida N
    Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.